{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T10:26:47Z","timestamp":1753439207165},"reference-count":41,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Bulletin du Cancer"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1684\/bdc.2014.1970","type":"journal-article","created":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T20:02:13Z","timestamp":1565726533000},"page":"511-520","source":"Crossref","is-referenced-by-count":6,"title":["Les r\u00e9cidives des tumeurs des voies a\u00e9rodigestives sup\u00e9rieures"],"prefix":"10.1016","volume":"101","author":[{"given":"Laurent","family":"Martin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustapha","family":"Zoubir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christophe","family":"Le Tourneau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1684\/bdc.2014.1970_bib0005","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1056\/NEJMoa032646","article-title":"Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck","volume":"350","author":"Cooper","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1684\/bdc.2014.1970_bib0010","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1097\/MLG.0b013e3180536705","article-title":"Salvage surgery with free flap reconstruction: factors affecting outcome after treatment of recurrent head and neck squamous carcinoma","volume":"117","author":"Kim","year":"2007","journal-title":"Laryngoscope"},{"key":"10.1684\/bdc.2014.1970_bib0015","unstructured":"Ho AS, Kraus DH, Ganly I. Decision making in the management of recurrent head and neck cancer 10.1002\/hed.23227 2012 Published online in Wiley Online Library (wileyonlinelibrary.com)"},{"key":"10.1684\/bdc.2014.1970_bib0020","doi-asserted-by":"crossref","first-page":"5518","DOI":"10.1200\/JCO.2007.15.0102","article-title":"Randomized trial of postoperative reirradiation combined with chemotherapy after salvage surgery compared with salvage surgery alone in head and neck carcinoma","volume":"26","author":"Janot","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1684\/bdc.2014.1970_bib0025","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/hed.20309","article-title":"Prognostic factors in salvage surgery for recurrent oral and oropharyngeal cancer","volume":"28","author":"Agra","year":"2006","journal-title":"Head Neck"},{"key":"10.1684\/bdc.2014.1970_bib0030","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/hed.2880130403","article-title":"Time to recurrence of squamous cell carcinoma of the head and neck","volume":"13","author":"Stell","year":"1991","journal-title":"Head Neck"},{"key":"10.1684\/bdc.2014.1970_bib0035","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.otohns.2010.01.024","article-title":"Factors predictive of successful outcome following salvage treatment of isolated neck recurrences","volume":"142","author":"Lim","year":"2010","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1684\/bdc.2014.1970_bib0040","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1684\/bdc.2013.1829","article-title":"\u00c9volution des concepts dans les cancers des voies a\u00e9rodigestives sup\u00e9rieures, sous l\u2019\u00e9gide de l\u2019Intergroupe ORL (GORTEC, GETTEC, GERCOR)","volume":"100","author":"Thariat","year":"2013","journal-title":"Bull Cancer"},{"key":"10.1684\/bdc.2014.1970_bib0045","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.otohns.2010.01.026","article-title":"Implications of head and neck cancer treatment failure in the neck","volume":"142","author":"Deschamps","year":"2010","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1684\/bdc.2014.1970_bib0050","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1053\/j.semradonc.2004.03.001","article-title":"Treatment of recurrent and advanced stage squamous cell carcinoma of the head and neck","volume":"14","author":"Arnold","year":"2004","journal-title":"Semin Radiat Oncol"},{"issue":"3","key":"10.1684\/bdc.2014.1970_bib0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00005537-200003001-00001","article-title":"Salvage surgery for patients with recurrent squamous cell carcinoma of the upper aerodigestive tract: when do the ends justify the means?","volume":"110","author":"Goodwin","year":"2000","journal-title":"Laryngoscope"},{"key":"10.1684\/bdc.2014.1970_bib0060","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.ijrobp.2010.02.023","article-title":"Prospective trial of high-dose reirradiation using daily image guidance with intensity-modulated radiotherapy for recurrent and second primary head-and-neck cancer","volume":"80","author":"Chen","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1684\/bdc.2014.1970_bib0065","doi-asserted-by":"crossref","first-page":"3556","DOI":"10.1200\/JCO.1998.16.11.3556","article-title":"Full-dose reirradiation for unresectable head and neck carcinoma: experience at the Gustave-Roussy Institute in a series of 169 patients","volume":"16","author":"De Crevoisier","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1684\/bdc.2014.1970_bib0070","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/hed.20697","article-title":"Final report of RTOG 9610, a multi-institutional trial of reirradiation and chemotherapy for unresectable recurrent squamous cell carcinoma of the head and neck","volume":"30","author":"Spencer","year":"2008","journal-title":"Head Neck"},{"key":"10.1684\/bdc.2014.1970_bib0075","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1200\/JCO.2005.05.3850","article-title":"Locally recurrent, previously irradiated head and neck cancer: concurrent re-irradiation and chemotherapy, or chemotherapy alone?","volume":"24","author":"Wong","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1684\/bdc.2014.1970_bib0080","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1470-2045(09)70311-0","article-title":"Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival","volume":"11","author":"Bonner","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1684\/bdc.2014.1970_bib0085","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ijrobp.2011.11.054","article-title":"Salvage stereotactic reirradiation with or without cetixumab for locally recurrent head and neck cancer: a feasibility study","volume":"84","author":"Comet","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1684\/bdc.2014.1970_bib0090","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1056\/NEJMoa0802656","article-title":"Platinum-based chemotherapy plus cetuximab in head and neck cancer","volume":"359","author":"Vermorken","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1684\/bdc.2014.1970_bib0095","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2011.29.15_suppl.5567","article-title":"Cetuximab, docetaxel, and cisplatin (TPEx) as first-line treatment in patients with recurrent or metastatic (R\/M) squamous cell carcinoma of the head and neck (SCCHN): first results of phase II trial GORTEC 2008-03","volume":"29","author":"Guigay","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1684\/bdc.2014.1970_bib0100","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1053\/j.seminoncol.2004.09.007","article-title":"Induction chemotherapy in locally advanced squamous cell cancer of the head and neck: evolution of the sequential treatment approach","volume":"31","author":"Posner","year":"2004","journal-title":"Semin Oncol"},{"key":"10.1684\/bdc.2014.1970_bib0105","first-page":"3579","article-title":"Elevated levels of transforming growth factor alpha and epidermal growth factor receptor messenger RNA are early markers of carcinogenesis in head and neck cancer","volume":"53","author":"Grandis","year":"1993","journal-title":"Cancer Res"},{"key":"10.1684\/bdc.2014.1970_bib0110","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1200\/JCO.1993.11.10.1873","article-title":"Expression of epidermal growth factor receptor and survival in upper aerodigestive tract cancer","volume":"11","author":"Dassonville","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1684\/bdc.2014.1970_bib0115","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1200\/JCO.2005.04.8306","article-title":"Epidermal growth factor receptor biology in head and neck cancer","volume":"24","author":"Kalyankrishna","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1684\/bdc.2014.1970_bib0120","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.bbamcr.2006.10.001","article-title":"Roles of the Raf\/MEK\/ERK pathway in cell growth, malignant transformation and drug resistance","volume":"1773","author":"McCubrey","year":"2007","journal-title":"Biochim Biophys Acta"},{"key":"10.1684\/bdc.2014.1970_bib0125","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.ccr.2005.03.003","article-title":"Structural basis for inhibition of the epidermal growth factor receptor by cetuximab","volume":"7","author":"Li","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1684\/bdc.2014.1970_bib0130","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/nrc1913","article-title":"Comparing antibody and small-molecule therapies for cancer","volume":"6","author":"Imai","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"10.1684\/bdc.2014.1970_bib0135","article-title":"Cisplatin (CDDP) and radiation versus cetuximab (Cx) and radiation in locally advanced head and neck squamous cell cancer (SCHNC): A retrospective review. 2012 ASCO Annual Meeting","volume":"30","author":"Prakash","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1684\/bdc.2014.1970_bib0140","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1200\/JCO.2006.06.7447","volume":"25","author":"Vermorken","year":"2007","journal-title":"Jco"},{"key":"10.1684\/bdc.2014.1970_bib0145","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1158\/1535-7163.MCT-10-0994","article-title":"PIK3CA mutations in patients with advanced cancers treated with PI3K\/AKT\/mTOR axis inhibitors","volume":"10","author":"Janku","year":"2011","journal-title":"Mol Cancer Ther"},{"key":"10.1684\/bdc.2014.1970_bib0150","first-page":"189","article-title":"Mechanisms underlying resistance to cetuximab in the HNSCC cell line: role of AKT inhibition in bypassing this resistance","volume":"38","author":"Rebucci","year":"2011","journal-title":"Int J Oncol"},{"key":"10.1684\/bdc.2014.1970_bib0155","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0092-8674(91)90403-L","article-title":"A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells","volume":"65","author":"G\u00fcnthert","year":"1991","journal-title":"Cell"},{"key":"10.1684\/bdc.2014.1970_bib0160","series-title":"Advances in cancer research","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0065-230X(08)60101-3","article-title":"CD44: Structure, function and association with the malignant process","author":"Naor","year":"1997"},{"key":"10.1684\/bdc.2014.1970_bib0165","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S1074-7613(04)00116-5","article-title":"The roles of the new negative T cell costimulatory pathways in regulating autoimmunity","volume":"20","author":"Khoury","year":"2004","journal-title":"Immunity"},{"key":"10.1684\/bdc.2014.1970_bib0170","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.it.2006.02.001","article-title":"The PD-1\u2013PD-L pathway in immunological tolerance","volume":"27","author":"Okazaki","year":"2006","journal-title":"Trends Immunol"},{"key":"10.1684\/bdc.2014.1970_bib0175","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1600-065X.2009.00767.x","article-title":"PD-1 signaling in primary T cells","volume":"229","author":"Riley","year":"2009","journal-title":"Immunological Reviews"},{"key":"10.1684\/bdc.2014.1970_bib0180","first-page":"6501","article-title":"B7-H1 blockade augments adoptive T-cell immunotherapy for squamous cell carcinoma","volume":"63","author":"Strome","year":"2003","journal-title":"Cancer Res"},{"key":"10.1684\/bdc.2014.1970_bib0185","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.oraloncology.2011.08.007","article-title":"Relationship between the expressions of PD-L1 and tumor-infiltrating lymphocytes in oral squamous cell carcinoma","volume":"47","author":"Cho","year":"2011","journal-title":"Oral Oncol"},{"key":"10.1684\/bdc.2014.1970_bib0190","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1158\/0008-5472.CAN-12-2384","article-title":"Evidence for a role of the PD-1: PD-L1 pathway in immune resistance of HPV-associated head and neck squamous cell carcinoma","volume":"73","author":"Lyford-Pike","year":"2013","journal-title":"Cancer Res"},{"key":"10.1684\/bdc.2014.1970_bib0195","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/nm730","article-title":"Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion","volume":"8","author":"Dong","year":"2002","journal-title":"Nat Med"},{"key":"10.1684\/bdc.2014.1970_bib0200","doi-asserted-by":"crossref","first-page":"17174","DOI":"10.1073\/pnas.0406351101","article-title":"Costimulatory B7-H1 in renal cell carcinoma patients: indicator of tumor aggressiveness and potential therapeutic target","volume":"101","author":"Thompson","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1684\/bdc.2014.1970_bib0205","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1200\/JCO.2009.26.7609","article-title":"Phase I study of singleagent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates","volume":"28","author":"Brahmer","year":"2010","journal-title":"J Clin Oncol"}],"container-title":["Bulletin du Cancer"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455115300990?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455115300990?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,1,16]],"date-time":"2021-01-16T17:17:22Z","timestamp":1610817442000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007455115300990"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S0007455115300990"],"URL":"https:\/\/doi.org\/10.1684\/bdc.2014.1970","relation":{},"ISSN":["0007-4551"],"issn-type":[{"value":"0007-4551","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]}}}